These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9402420)

  • 1. [Mibefradil: a new class calcium inhibitor].
    Internist (Berl); 1996 Oct; 37(10 Suppl Mibefradil):1-8. PubMed ID: 9402420
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mibefradil opens up a new class of calcium antagonists. Glasgow, 23 June 1996].
    Dtsch Med Wochenschr; 1996 Sep; 121(39 Suppl):1-4. PubMed ID: 9212757
    [No Abstract]   [Full Text] [Related]  

  • 3. Mibefradil (posicor).
    Giles TD
    Compr Ther; 1997 Nov; 23(11):761-3. PubMed ID: 9360806
    [No Abstract]   [Full Text] [Related]  

  • 4. [Introducing mibefradil--a new T-calcium channel blocker].
    Internist (Berl); 1997 Dec; 38(12 Suppl Mibefradil):1-4. PubMed ID: 9437250
    [No Abstract]   [Full Text] [Related]  

  • 5. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
    Brogden RN; Markham A
    Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mibefradil: a new twist to the calcium channel antagonist.
    Lynn MM
    Nurse Pract; 1998 May; 23(5):100, 102-4, 106-7. PubMed ID: 9614683
    [No Abstract]   [Full Text] [Related]  

  • 7. Mibefradil: a new class of calcium-channel antagonists.
    Billups SJ; Carter BL
    Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of antihypertensive therapy with calcium antagonists: the new molecules].
    Pirrelli A; Vulpis V
    Cardiologia; 1998 Apr; 43(4):357-64. PubMed ID: 9659793
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy and safety of mibefradil in subgroups of patients with chronic stable angina pectoris.
    Charlon V; Kobrin I
    Int J Clin Pract; 1998 Jun; 52(4):257-64. PubMed ID: 9744152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mibefradil, a pharmacologically distinct calcium antagonist.
    Ernst ME; Kelly MW
    Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacological and clinical outlook for mibefradil--a new selective T-type calcium channel antagonist].
    Eliseev OM
    Ter Arkh; 1998; 70(8):87-8. PubMed ID: 9841457
    [No Abstract]   [Full Text] [Related]  

  • 12. Mibefradil--a new calcium-channel blocker.
    Med Lett Drugs Ther; 1997 Nov; 39(1013):103-5. PubMed ID: 9391500
    [No Abstract]   [Full Text] [Related]  

  • 13. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
    Davies GJ; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):34C-39C. PubMed ID: 9286852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of calcium antagonists.
    Pitt B
    Clin Ther; 1997; 19 Suppl A():3-17. PubMed ID: 9385501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential properties of mibefradil in hypertension and angina.
    Kobrin I
    J Hypertens Suppl; 1997 Dec; 15(5):S33-40. PubMed ID: 9481614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of bradycardia by mibefradil in antihypertensive combination therapy].
    Wagner J; Ritz E
    Dtsch Med Wochenschr; 1998 Apr; 123(17):547. PubMed ID: 9601479
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic and clinical perspectives on mibefradil: a new T-channel selective calcium antagonist: introduction.
    Giles TD
    Am J Cardiol; 1997 Aug; 80(4B):1C-3C. PubMed ID: 9286847
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: a multicenter, double-blind, placebo-controlled, randomized comparison with sustained-release diltiazem.
    Davies GJ; Kobrin I; Caspi A; Reisin LH; de Albuquerque DC; Armagnijan D; Coelho OR; Schneeweiss A
    Am Heart J; 1997 Aug; 134(2 Pt 1):220-8. PubMed ID: 9313601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.
    Alpert JS
    Clin Cardiol; 1998 Feb; 21(2):129. PubMed ID: 9491954
    [No Abstract]   [Full Text] [Related]  

  • 20. Mibefradil: a selective T-type calcium antagonist.
    Massie BM
    Am J Cardiol; 1997 Nov; 80(9A):23I-32I. PubMed ID: 9375939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.